• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical Outcomes and Molecular Characteristics of Infections.感染的临床结局与分子特征
Ann Lab Med. 2025 Mar 1;45(2):223-227. doi: 10.3343/alm.2024.0369. Epub 2024 Oct 31.
2
Genotypic and phenotypic diversity of carbapenem-resistant Bacteroides fragilis strains collected from different clinical origins.从不同临床来源收集的耐碳青霉烯类脆弱拟杆菌菌株的基因型和表型多样性。
Anaerobe. 2025 Feb;91:102924. doi: 10.1016/j.anaerobe.2024.102924. Epub 2024 Dec 4.
3
Emergence of carbapenem resistance in Bacteroides fragilis in China.中国脆弱拟杆菌中产碳青霉烯酶耐药的出现。
Int J Antimicrob Agents. 2019 Jun;53(6):859-863. doi: 10.1016/j.ijantimicag.2019.02.017. Epub 2019 Mar 1.
4
Fatal sepsis caused by multidrug-resistant Bacteroides fragilis, harboring a cfiA gene and an upstream insertion sequence element, in Japan.在日本,携带cfiA基因和上游插入序列元件的耐多药脆弱拟杆菌引起的致命性败血症。
Anaerobe. 2017 Apr;44:36-39. doi: 10.1016/j.anaerobe.2017.01.010. Epub 2017 Jan 17.
5
Detection of B. fragilis group and diversity of bft enterotoxin and antibiotic resistance markers cepA, cfiA and nim among intestinal Bacteroides fragilis strains in patients with inflammatory bowel disease.炎症性肠病患者肠道脆弱拟杆菌菌株中脆弱拟杆菌群的检测以及bft肠毒素和抗生素耐药标记物cepA、cfiA和nim的多样性
Anaerobe. 2018 Apr;50:93-100. doi: 10.1016/j.anaerobe.2018.02.005. Epub 2018 Feb 14.
6
Antibiotic resistance pattern of Bacteroides fragilis isolated from clinical and colorectal specimens.脆弱拟杆菌的临床和结直肠标本分离株的抗生素耐药模式。
Ann Clin Microbiol Antimicrob. 2021 Apr 23;20(1):27. doi: 10.1186/s12941-021-00435-w.
7
Prevalence and antimicrobial susceptibility of enterotoxigenic extra-intestinal Bacteroides fragilis among 13-year collection of isolates in Kuwait.科威特 13 年分离株中肠外产毒脆弱拟杆菌的流行情况和抗菌药物敏感性。
BMC Microbiol. 2020 Jan 15;20(1):14. doi: 10.1186/s12866-020-1703-4.
8
The prevalence of enterotoxin and antibiotic resistance genes in clinical and intestinal Bacteroides fragilis group isolates in Turkey.土耳其临床和肠道脆弱拟杆菌群分离株中肠毒素和抗生素抗性基因的流行情况。
Anaerobe. 2015 Oct;35(Pt B):72-6. doi: 10.1016/j.anaerobe.2015.07.008. Epub 2015 Jul 26.
9
[Can meropenem E-test be used to estimate the presence of carbapenem resistance gene cfiA among Bacteroides fragilis strains?].[美罗培南E试验能否用于评估脆弱拟杆菌菌株中碳青霉烯耐药基因cfiA的存在情况?]
Mikrobiyol Bul. 2011 Jul;45(3):385-91.
10
Frequency and associated factors for carbapenem-non-susceptible Bacteroides fragilis group bacteria colonization in hospitalized patients: Case control study in a university hospital in Turkey.住院患者中产脆弱拟杆菌群细菌碳青霉烯耐药的定植频率及其相关因素:土耳其一所大学医院的病例对照研究。
Indian J Med Microbiol. 2021 Oct-Dec;39(4):518-522. doi: 10.1016/j.ijmmb.2021.03.018. Epub 2021 Mar 31.

本文引用的文献

1
Antimicrobial susceptibility of Bacteroides fragilis group organisms in Hong Kong, 2020-2021.2020-2021 年香港脆弱拟杆菌群细菌的抗菌药物敏感性。
Anaerobe. 2023 Aug;82:102756. doi: 10.1016/j.anaerobe.2023.102756. Epub 2023 Jul 8.
2
Development and Clinical Application of a Multilocus Sequence Typing Scheme for Based on Whole-Genome Sequencing Data.基于全基因组测序数据的[具体研究对象]多位点序列分型方案的开发与临床应用 。(注:原文中“for”后面缺少具体内容)
Microbiol Spectr. 2023 Mar 21;11(2):e0511122. doi: 10.1128/spectrum.05111-22.
3
Time for Some Group Therapy: Update on Identification, Antimicrobial Resistance, Taxonomy, and Clinical Significance of the Bacteroides fragilis Group.是时候进行一些小组治疗了:脆弱拟杆菌群的鉴定、抗菌耐药性、分类学和临床意义的最新进展。
J Clin Microbiol. 2022 Sep 21;60(9):e0236120. doi: 10.1128/jcm.02361-20. Epub 2022 Jun 14.
4
Comparative Genomics of Bacteroides fragilis Group Isolates Reveals Species-Dependent Resistance Mechanisms and Validates Clinical Tools for Resistance Prediction.脆弱拟杆菌群分离株的比较基因组学揭示了种依赖性的耐药机制,并验证了用于耐药预测的临床工具。
mBio. 2022 Feb 22;13(1):e0360321. doi: 10.1128/mbio.03603-21. Epub 2022 Jan 18.
5
Rapid detection and surveillance of cfiA-positive Bacteroides fragilis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry.使用基质辅助激光解吸电离飞行时间质谱法快速检测和监测 cfiA 阳性脆弱拟杆菌。
Anaerobe. 2021 Dec;72:102448. doi: 10.1016/j.anaerobe.2021.102448. Epub 2021 Sep 17.
6
To resist and persist: Important factors in the pathogenesis of Bacteroides fragilis.抵抗和坚持:脆弱拟杆菌发病机制中的重要因素。
Microb Pathog. 2020 Dec;149:104506. doi: 10.1016/j.micpath.2020.104506. Epub 2020 Sep 17.
7
The gut microbiota and colon cancer.肠道微生物群与结肠癌
Science. 2019 Jun 21;364(6446):1133-1135. doi: 10.1126/science.aaw2367.
8
Emergence of carbapenem resistance in Bacteroides fragilis in China.中国脆弱拟杆菌中产碳青霉烯酶耐药的出现。
Int J Antimicrob Agents. 2019 Jun;53(6):859-863. doi: 10.1016/j.ijantimicag.2019.02.017. Epub 2019 Mar 1.
9
High prevalence of division II (cfiA positive) isolates among blood stream Bacteroides fragilis in Slovenia as determined by MALDI-TOF MS.MALDI-TOF MS 鉴定斯洛文尼亚血流感染脆弱拟杆菌 II 型(cfiA 阳性)分离株的高流行率。
Anaerobe. 2019 Aug;58:30-34. doi: 10.1016/j.anaerobe.2019.01.011. Epub 2019 Feb 1.
10
Antimicrobial Susceptibility Patterns of Anaerobic Bacterial Clinical Isolates From 2014 to 2016, Including Recently Named or Renamed Species.2014 年至 2016 年临床分离的厌氧细菌的抗菌药物敏感性模式,包括最近命名或更名的菌种。
Ann Lab Med. 2019 Mar;39(2):190-199. doi: 10.3343/alm.2019.39.2.190.

感染的临床结局与分子特征

Clinical Outcomes and Molecular Characteristics of Infections.

作者信息

Kim Bongyoung, Kim Myungsook, Lee Kyungwon, Lee Yangsoon

机构信息

Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.

Seoul Clinical Laboratory, Yongin, Korea.

出版信息

Ann Lab Med. 2025 Mar 1;45(2):223-227. doi: 10.3343/alm.2024.0369. Epub 2024 Oct 31.

DOI:10.3343/alm.2024.0369
PMID:39478317
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11788700/
Abstract

is the most common opportunistic anaerobic pathogen. In the absence of appropriate antimicrobial therapy, mortality rates associated with group infections can reach as high as 50%. Therefore, we aimed to elucidate the clinical characteristics and outcomes of infections and the molecular genetic characteristics of isolates. Forty clinical isolates were collected at Hanyang University Hospital between January 2022 and December 2023. Antimicrobial susceptibility was tested using the agar dilution method. Whole-genome sequencing was conducted using the Illumina platform (Illumina, San Diego, CA, USA). Various multilocus sequence types of were identified, including ST149 (N=4), ST11 (N=4), ST1 (N=3), ST21 (N=2), and ST157 (N=1). The insertion sequence (IS) IS, located upstream of , was associated with high-level carbapenem resistance in the ST157 isolate. toxin genes (bft ) were identified in 30% of isolates. The most common comorbidities were diabetes mellitus (26.5%) and non-metastatic cancer (23.5%). Five patients (14.7%) died within 30 days, and two (5.9%) deaths were directly attributable to infection. The emergence of high-level MIC carbapenem-resistant ST157 has led to caution in the presence of infections.

摘要

是最常见的机会性厌氧病原体。在缺乏适当抗菌治疗的情况下,与该菌感染相关的死亡率可高达50%。因此,我们旨在阐明该菌感染的临床特征和结局以及该菌分离株的分子遗传学特征。2022年1月至2023年12月期间,在汉阳大学医院收集了40株临床分离株。采用琼脂稀释法检测抗菌药物敏感性。使用Illumina平台(美国加利福尼亚州圣地亚哥的Illumina公司)进行全基因组测序。鉴定出该菌的多种多位点序列类型,包括ST149(N = 4)、ST11(N = 4)、ST1(N = 3)、ST21(N = 2)和ST157(N = 1)。位于该菌上游的插入序列(IS)IS与ST157分离株的高水平碳青霉烯耐药性相关。在30%的分离株中鉴定出该菌毒素基因(bft)。最常见的合并症是糖尿病(26.5%)和非转移性癌症(23.5%)。5例患者(14.7%)在30天内死亡,2例(5.9%)死亡直接归因于该菌感染。高水平耐碳青霉烯的ST157菌的出现使得在出现该菌感染时需谨慎对待。